Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 589.79M | 551.56M | 522.34M | 559.07M | 580.19M |
Gross Profit | 145.75M | 133.87M | 98.42M | 97.31M | 2.23M |
EBITDA | -87.90M | -15.39M | -130.39M | 19.35M | -134.10M |
Net Income | -98.33M | -46.91M | -160.74M | -53.18M | -174.51M |
Balance Sheet | |||||
Total Assets | 316.20M | 377.95M | 420.13M | 538.67M | 681.90M |
Cash, Cash Equivalents and Short-Term Investments | 21.57M | 18.56M | 16.21M | 31.67M | 17.17M |
Total Debt | 533.76M | 491.00M | 455.01M | 462.39M | 486.97M |
Total Liabilities | 621.14M | 581.49M | 569.14M | 537.18M | 620.90M |
Stockholders Equity | -304.94M | -203.54M | -149.01M | 1.49M | 61.00M |
Cash Flow | |||||
Free Cash Flow | 10.81M | -49.00K | -46.87M | -56.67M | -122.71M |
Operating Cash Flow | 15.83M | 4.31M | -40.86M | -54.01M | -98.68M |
Investing Cash Flow | 1.84M | 2.22M | -3.93M | 13.50M | -28.45M |
Financing Cash Flow | -21.64M | -4.18M | 29.33M | 53.80M | 84.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $20.97B | 14.57 | -8.07% | 3.14% | 2.79% | -9.97% | |
40 Underperform | AU$49.88M | ― | ― | 4.22% | -199.40% | ||
― | €17.76M | ― | -23.00% | ― | ― | ― | |
― | €9.23M | ― | -240.42% | ― | ― | ― | |
48 Neutral | AU$24.89M | ― | -47.74% | ― | 43.14% | 51.35% | |
― | AU$5.99M | ― | ― | ― | ― | ||
57 Neutral | AU$33.50M | ― | ― | -5.86% | 98.26% |
Noumi Limited reported a slight decline in Q4 FY25 revenue to $155.2 million, with plant-based milks experiencing a 2.9% decrease, while dairy and nutritionals saw a 0.9% increase. Despite a negative operating cash flow of $2.2 million due to legal expenses, the company maintained a positive annual operating cash flow of $32.5 million. Noumi is optimistic about its FY25 earnings, expecting improved operating EBITDA, although it anticipates a net loss after tax due to depreciation, financing costs, and impairment charges. The company continues to see strong performance from its Milklab brand, particularly in retail and export channels, despite competitive pressures and macroeconomic challenges.
The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.
Noumi Limited has announced that the Victorian Supreme Court has approved the settlement terms of a class action lawsuit, marking the resolution of a significant legacy issue for the company. With the settlement, which includes Noumi’s $11.56 million contribution covered by insurance, the company can now focus on business growth and enhancing stakeholder value, as it moves past the financial restatements of FY19 and FY20.
The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.